Skip to content
10-K

Annual Report

QLY BIOTECH GROUP CORP.

0001477932-21-008726

← back to feed
Filed
Nov 22, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Nov 19, 2021 3.9M sh
Capex FY 2021 · Aug 31, 2021 $0
Capex restated FY 2021 · Aug 31, 2020 $5.14K
Operating Income FY 2021 · Aug 31, 2021 $29.5K
Operating Cash Flow FY 2021 · Aug 31, 2020 −$3.9K
Cash And Equivalents FY 2021 · Aug 31, 2020 $27.63K
Cash And Equivalents FY 2021 · Aug 31, 2019 $5K
Current Liabilities FY 2021 · Aug 31, 2020 $7.8K
Total Liabilities FY 2021 · Aug 31, 2020 $7.8K
Current Assets FY 2021 · Aug 31, 2020 $27.63K
Total Assets FY 2021 · Aug 31, 2020 $31.34K
Sga Expense FY 2021 · Aug 31, 2020 $7.93K
Net Income FY 2021 · Aug 31, 2020 −$5.33K
Gross Profit FY 2021 · Aug 31, 2020 $2.6K
Cost Of Revenue FY 2021 · Aug 31, 2020 $1.4K
Revenue FY 2021 · Aug 31, 2020 $4K
Stockholders Equity FY 2021 · Aug 31, 2019 $2.02K